fbpx

Australian’s affected by bushfires will be able to access their medicines in an emergency at PBS prices

A temporary expansion of PBS Continued Dispensing to cover nearly all PBS medicines will mean Australians affected by the bushfire crisis will be able to access their vital medicines at regular PBS prices if they find themselves without a prescription, following a move strongly welcomed by the Pharmaceutical Society of Australia (PSA).

 

Under the temporary change announced this afternoon by Health Minister Hon Greg Hunt, from Monday 13 January 2020, pharmacists will be able to offer standard quantities of ongoing PBS medicines for the standard co-payment– being $6.60 for concession card holders, and up to a maximum of $41.00 for general patients – where PBS medicines are supplied without a prescription in an emergency situation.

 

This move supports the recent issue of temporary authorities to legally supply full-supplies of these medicines in an emergency in New South Wales, Victoria and the ACT.

 

Prior to this announcement, the PBS Continued Dispensing initiative only applied to PBS-listed oral contraceptives and cholesterol lowering medicines. This meant consumers were unable to access PBS subsidies when pharmacists supplied most medicines under emergency supply provisions. This resulted in patients suffering significant surprise out-of-pocket costs when accessing medicines in an emergency.

 

Natalie Thorton was evacuated from Eden to Merimbula with her husband and children. The last matter on her mind was remembering to take any prescription medicines with her. Mrs Thorton said “an emergency evacuation from an out of control bushfire was so traumatic, being able to walk in to the pharmacy and get the medicines my family required in a caring and supportive environment was one less thing that I had to worry about”.

 

In welcoming the move, PSA National President Associate Professor Chris Freeman said, “PSA have been working with the government and its departments on this issue for many months and we congratulate the leadership shown by the Health Minister on today’s announcement.”

 

“The last thing people need in the middle of this crisis is to find the money to pay for their medicines which would have otherwise been subsidised. This provision will make a huge different to unfair and unexpected out-of-pocket medicine expenses for people who are displaced by fires.”

 

“PSA’s existing Guidelines for the continued dispensing of eligible prescribed medicines by pharmacists provide clear information to pharmacists on how to appropriately supply of medicines in these situations. I am confident pharmacists will adhere to these requirements when supplying PBS medicines under this temporary expansion.

 

PSA believes more work is needed to enable provisions to be automatically available when the next disaster strikes.

 

“We are keen to work with the federal government in collaboration with their state and territory counterparts after this crisis subsides to permanently incorporate effective and nationally consistent emergency supply provisions,” Associate Professor Freeman noted.

 

“PSA will continue to advocate for a long term solution on behalf of all Australians. We need nationally consistent emergency supply rules for medicines which ensure patients get the medicines they urgently need at the price they know and can afford” said Associate Professor Freeman.

 

The expanded PBS Continued Dispensing provisions takes effect from Monday 13 January 2020 and expires on 31 March 2020.

 

PSA will communicate this temporary change to pharmacists in addition to information published on the Department of Health website via www.pbs.gov.au.

 

Download media release here

ACT joins NSW and Victoria in improving access to medicines for people affected by bushfires

Friday, 10 January 2020

 

People in the ACT affected by the bushfire crisis will now be able to access a standard PBS or manufacturers’ pack quantity of their Prescription Only Medicines (Schedule 4) without a prescription following the issuing of a temporary authority by the ACT Chief Health Officer, a move welcomed by the Pharmaceutical Society of Australia (PSA).

 

The emergency provision brings the ACT into line with New South Wales and Victoria following similar announcements in the past two days. Under the special authority pharmacists will be able to supply standard pack sizes, usually one month’s supply, to people affected by the bushfires where it is not practical to get a prescription.

 

Prior to this special authority being issued, ACT pharmacists were unable to supply more than three (3) days’ supply of a Prescription Only Medicine without a prescription in an emergency.

 

In welcoming the announcement, PSA ACT Branch Vice President Professor Mark Naunton said: “This is a sensible decision made by ACT Health to ensure patients maintain their access to medicines consistent with other affected states in the ACT region. The current bushfire crisis is starting to create an increased demand on Canberra’s pharmacists from patients who have been displaced from NSW and Victoria and are coming into the ACT.”

 

“Our community pharmacists are working incredibly hard to ensure this increased demand is managed to ensure patients are not adversely affected by this crisis, and this change helps pharmacists care for these people.”

 

“ACT’s pharmacists thank the ACT Health CHO for aligning so quickly to the changes made by NSW and Victoria to ensure consistency in emergency access to medicines in what can be a very confusing time for displaced people.

 

Controlled Drugs (Schedule 8) (e.g. opioid pain medicines), anabolic steroids, benzodiazepines and a small number of specialised medicines (‘Appendix D medicines’) cannot be supplied under this provision.

 

PSA National President Associate Professor Chris Freeman also welcomed the move: “The ACT is the third jurisdiction to recognise the challenges associated with accessing vital medicines in an emergency. PSA will continue to work with state and territory governments around the country to improve regulations regarding access to prescription medicines in emergency situations.”

 

The special provision takes effect immediately and expires on 31 March 2020. PSA will distribute guidance to Canberra pharmacists in addition to information published on the ACT Health website.

 

Media contact: PSA Media, 0487 922 176

 

Download media release

Victorian government acts to ensure people affected by bushfires can access essential medicines without a prescription

Victorian residents affected by the bushfire crisis will now be able to access a standard PBS or manufacturers’ pack quantity of their Prescription Only Medicines (Schedule 4) without a prescription following gazettal of a public health emergency order today, a move strongly welcomed by the Pharmaceutical Society of Australia (PSA).

 

Under the public health emergency order, Victorian pharmacists will be able to supply people affected by the bushfires with standard PBS quantities and smallest standard pack sizes of non-PBS medicines without a prescription when where a pharmacist is satisfied there is an immediate therapeutic need and obtaining a prescription is impractical. In most cases, this represents a months’ supply of that medicine.

 

Mallacoota pharmacist Emmanuel Chifefe Manzai said, “Until today in Victoria, if a pharmacist is satisfied that it is not possible for a patient to get a prescription for their chronic medicines the pharmacist is only allowed to give three days’ supply as an emergency.”

 

“I’m pleased this archaic regulation has been removed as it does not help patients especially in disasters like we are currently experiencing.  Patients are stuck here for weeks; giving them three days’ supply is just ridiculous. Mr Manzai continued “I’m pleased Victorian authorities have followed what the NSW government has done, by allowing pharmacists to dispense a PBS-quantity without a script in areas affected by the bush fires”

 

PSA National President Associate Professor Chris Freeman welcomed the announcement, noting “Victorian pharmacists working in affected areas, have stood up and gone above and beyond in supporting the health of their communities in this crisis. But up until now, the inability to supply more than three-days’ supply of medicines to people has been an unacceptable barrier to accessing and providing care to people in these fire affected zones.”

 

“This announcement means people separated from their prescription medicines or prescriptions will be able to access their regular medicines needed for managing chronic health conditions, such as blood pressure, depression, diabetes, asthma or chronic obstructive pulmonary disease (COPD).”

 

As part of the order, pharmacists must record that the sale or supply was made under the public health emergency order.  The order does not apply to Schedule 8 medicines (Controlled Drugs).

 

“We thank Minister Mikakos for responding to this urgent need and arranging this public health order.” Associate Professor Freeman said “We believe this is the first time such a public health order has been gazetted in Victoria.”

 

“PSA are keen to work with the Minister and her department after this crisis subsides to review how this provision could become engrained in regulation to ensure people are able to access medicines when the next emergency strikes.”

 

“PSA will be following up with all other states and territories to ensure these provisions can be enacted quickly should the time arise this bushfire season.”

 

“The next step is also to enable access to PBS subsidy for medicines supplied in emergencies so patients do not have the shock of unexpected out-of-pocket expenses when accessing the regular medicines during a crisis.”

 

The special provision takes effect immediately and is in force until midnight 1 April 2020 unless revoked.

 

PSA has distributed guidance to Victorian pharmacists this afternoon to communicate the order and guidance on the Victorian Government website at https://www2.health.vic.gov.au/public-health/drugs-and-poisons

 

Media contact: PSA Media, 0487 922 176

 

Download media release

Landmark Special Authority for NSW Residents Affected by Bushfires to Access Essential Medicines Without a Prescription

Wednesday, 8 January 2020

 

New South Wales (NSW) residents affected by the bushfire crisis will now be able to access a standard PBS or manufacturers pack quantity of their Prescription Only Medicines (Schedule 4) without a prescription following the issuing of a special authority by the NSW Chief Health Officer, a move strongly welcomed by the Pharmaceutical Society of Australia (PSA).

 

 

Under the special authority announced last night, NSW pharmacists will be able to supply people affected by the bushfires with standard PBS quantities and standard pack sizes of non-PBS medicines without a prescription when where a pharmacist is satisfied there is an immediate therapeutic need and obtaining a prescription is impractical. In most cases, this represents a months’ supply of that medicine.

 

 

Malua Bay Pharmacist, Raj Gupta, has kept his pharmacy doors open in the fires said “Patients I have known for years have come into my pharmacy having lost all their medicines in the fires. When you have lost your home, there is no power or telephone and it might be weeks before you can get in to see a doctor, to turn them away with just a few days of life saving medicines to tide them over because of some bureaucratic rule – it just needs to be fixed.
Prior to this special authority being issued, pharmacists were unable to supply more than three (3) days’ supply of a Prescription Only Medicine without a prescription in an emergency.

 

 

In welcoming the announcement, the PSA NSW Branch President Peter Carroll noted “The current bushfires across NSW have resulted in unprecedented demand on pharmacists working in multiple settings, especially in community pharmacy”.

 

 

“We have heard many stories and first-hand examples of pharmacists going above and beyond in their support of their communities. But up until now, the inability to supply more than three-days’ supply of medicines to people has been an unacceptable barrier to accessing and providing care to people in these disaster affected zones.”

 

 

“This announcement means that people separated from their prescription medicines or prescriptions will be able to access their regular medicines needed for managing chronic health conditions, such as blood pressure, depression, diabetes, asthma or chronic obstructive pulmonary disease (COPD).
Similar to other emergency supply provisions, Schedule 4 Appendix D medicines (e.g. benzodiazepines) and Controlled Drugs (Schedule 8) (e.g. opioid pain medicines) cannot be supplied under this provision unless authorised by a medical practitioner by telephone, email or facsimile.”

 

 

“We thank the NSW Ministry of Health for responding to this urgent need and issuing this special authority which is vital to ensure NSW residents affected by bushfires can continue access to medicines vital for their health.” Prof Carroll said “We understand this is the first time such a special authority has been issued in Australia.”

 

 

“Unfortunately, emergencies and disasters are regular events in NSW. We are keen to work with the NSW government after this crisis subsides to review how this provision could become engrained in regulation to ensure people are able to access medicines when the next emergency strikes.”

 

 

PSA National President, Associate Professor Chris Freeman congratulated the NSW Ministry of Health on this pragmatic and important solution in improving access to medicines in disaster situations. Associate Professor Freeman said “The NSW Government has been the first to listen to calls from the national peak body representing pharmacists. The NSW Government has shown leadership, compassion and a willingness to ensure NSW residents affected by these unprecedented fires can have safe access to medicines in an emergency”.

 

 

“The PSA will continue to advocate on behalf of Australians affected by the bushfires and their amazing and courageous pharmacists who care for them, to have nationally consistent emergency supply rules for medicines without having to foot the bill” said Associate Professor Freeman.
The special provision takes effect immediately and expires on 31 March 2020. PSA will distribute guidance to NSW pharmacists in addition to information published on the NSW Health website.

 

 

Media contact: PSA Media, 0487 922 176

 

 

Download media release here

 

Community pharmacists supporting smoke-affected Canberrans

As Canberra’s air quality is set to deteriorate again tonight, Canberrans most vulnerable to the effects of poor air quality due to the bushfire smoke blanketing the ACT can attend their local pharmacist for advice and to access one of the 100,000 Commonwealth Government supplied P2 masks delivered to every community pharmacy across the Territory this week.
 
“Around the country, pharmacists have rallied in support of their communities and are doing what they can to help as bushfires devastate so many parts of Australia,” Pharmaceutical Society of Australia ACT Vice President, Professor Mark Naunton said.
 
“In the ACT this week, pharmacists have stepped up to coordinate and provide access to protective masks for Canberrans most sensitive to smoke, such as those over 65, pregnant women and people with chronic health conditions such as asthma and cardiovascular disease.”
 
Yesterday the Commonwealth Government delivered 100,000 P2 masks to the nation’s capital and staff from the Pharmaceutical Society of Australia and the Pharmacy Guild of Australia joined forces to work with ACT Health to get them to community pharmacies as their final destination.
 
Simon Blacker, ACT President of the Pharmacy Guild of Australia reflected; “What I saw when I was delivering masks for vulnerable people to ACT community pharmacies was a mixture of joy and relief that masks were arriving that would allow the pharmacy to be able to help their local communities and their local patients. The teams of pharmacists and staff were excited to be empowered to help, and this is a common trait of all community pharmacies and those that work within them.”
 
“As we travelled around the city and visited each of Canberra’s 80 pharmacies was a network of community pharmacists eager to help out and play a part in keeping Canberrans safe from the harmful effects of pollution,” Prof. Naunton said. “This is another example of the important role pharmacists play in responding to public health issues and natural disasters.”
 
“By the time the task was completed yesterday afternoon, we believe about one-third of masks had already been provided free of charge to members of our community, showing how urgent the need in Canberra was,” Mr Blacker said.
 
Mr Blacker urged Canberrans to contact their local pharmacy for any queries regarding availability; “Access to this supply of masks is being prioritised for Canberrans whose health is at risk due to smoke. Anyone who falls in this category is encouraged to visit their local pharmacy. If your local pharmacy has run out, another nearby is likely to have some available.”


IMPORTANT HEALTH ADVICE:

  • The community are reminded that up to date health advice and further information on how to use a P2/N95 mask properly is on the ACT Health website (www.health.act.gov.au).
  • The community are also reminded that use of masks is also not an alternative to avoiding exposure to the smoke outdoors.
  • The best way to protect yourself and your family is to stay indoors (with windows and doors closed) when heavy smoke is around.

Media contact
PSA Media, 0487 922 176
Pharmacy Guild of Australia (ACT Branch), Simon Blacker 0418 477 168
 

Download media release here

Bushfire Support

The current bushfires across Australia have resulted in unprecedented demand on pharmacists working in multiple settings, especially in community pharmacy.
 
PSA have heard many stories and first hand examples of pharmacists going above and beyond in their support of their communities. We have also heard of barriers to accessing and providing care in these disaster affected zones.
 
PSA have been in contact with the Commonwealth Department of Health, the office of the Commonwealth Health Minister, and the Australian Defence Force. PSA will continue to provide advice to these agencies about the requirements on the ground.
 
Members who are experiencing challenges in delivering care to their local communities can email bushfires@psa.org.au and we will pass on your requirements to the relevant State and or Commonwealth Departments.
 
These issues may be in the context of the following

  • Logistical supplies of medicines
  • Workforce support
  • Power interruption
  • Payment of medicines
  • Mental health support for staff.

 
In the long term we will continue to address two major areas of concern for you and for your patients:

  • The need for more flexible emergency supply arrangements, especially in disaster periods
  • The need for meaningful support for community pharmacy in disaster planning and preparedness.

 
PSA are seeking advice regarding the supply of Schedule 3 medicines during this period from the relevant state health departments, and will provide advice when this available. In the absence of specific information from State health departments regarding the supply of medicines in these circumstances, including salbutamol, we urge pharmacists to exercise their professional judgment in the appropriate supply of medicines.
 
Times like this can be very hard, even for those not directly affected. If you or your staff require support, you can access the Pharmacists’ Support Service by calling 1300 244 910.
 
Beyond Blue have some good resources that you, your staff and community may find beneficial during this time, including this guide to looking after yourself in a disaster.
 
I hope and trust that you all remain safe.
 

A/Prof Chris Freeman
National President
Pharmaceutical Society of Australia

Next level intern training

The market leader that gives you more including FREE PSA membership and immunisation training.

 

Budget boost could help save lives

Monday, 16 November 2019

 

The Pharmaceutical Society of Australia has called on the Victorian Government to make Medication Assisted Treatment for Opioid Dependence (MATOD) more affordable in order to save lives.

 

In its 2020-21 Pre-Budget Submission, PSA identified four priority areas of action where funding will have a significant impact on health care and outcomes.
“Australian Bureau of Statistics (ABS) data suggests 298 people in Victoria lost their lives last year due to opioid induced deaths.” Pharmaceutical Society of Australia Victorian President, Ben Marchant said. “Every one of these members of our community were someone’s friend or family member and leave behind grieving loved ones.”

 

MATOD programs support people living with a substance use disorder and provide stability and a pathway to rehabilitation through daily dosing of long-acting opioid medicines such as methadone.

 

PSA understands there are approximately 14,000 people currently utilising the program in Victoria, but there are substantial barriers to access.

 

“Cost is a significant barrier,” Mr Marchant explained. “While the medicines are free, the cost for safe, witnessed dosing is currently met by the patient. This is out of step with other states where these services can be fully government funded.”

 

In Victoria, MATOD services are nearly exclusively provided through community pharmacies.

 

“We are proposing a co-payment model. The Victorian Government would provide funds for this service in order to reduce patient out of pockets costs – making access more affordable – while ensuring pharmacists are adequately remunerated and able to offer this important service,” Mr Marchant said.

 

PSA has also warned that some of Victoria’s most vulnerable population groups, including children, the ill, elderly and infirm, are being put at risk due to the low vaccination rates of those who care for them.

 

“For example, less than 50 per cent of childcare workers are fully vaccinated and seasonal influenza vaccination uptake is inconsistent in aged care and health care workers,” Mr Marchant revealed.

 

To increase vaccination rates in Victoria, PSA is recommending expanding the range of vaccines trained pharmacists are able to administer in line with proposals in the current Department of Health and Human Services (Victoria) vaccination consultation and to include all vaccines recommended for health care workers and carers.

 

PSA’s Pre-Budget Submission also calls on the Government to establish the role of Victorian Chief Pharmacist and allocate $500,000 to upskill pharmacists in mental health first aid.

 

“Nearly half of all Australians will experience a mental health illness in their lifetime,” Mr Marchant said. “Mental health challenges are even more common in rural and remote areas where pharmacists are often the most accessible healthcare professional.

 

“Pharmacists are well placed to support patients in the community and identify them early so they can be referred to appropriate mental health providers, including general practitioners.

 

In Victoria, there are 7,443 registered pharmacists working in community pharmacies, hospital, general practice, aged care, Victorian and federal government and within other private sector organisations.

 

PSA’s Victorian Budget submission can be found here.

 

Media contact: Stefanie Johnston, PSA Victoria – 0417 910 738

 

Download media release

Budget an opportunity to improve health care for Tasmanians

The state’s 784 registered pharmacists could help significantly improve the health of Tasmanians with implementation of a few relatively low cost or no-cost measures, the Pharmaceutical Society of Australia has championed in its 2020-21 Pre-Budget Submission.

 

A key recommendation is to more fully utilise pharmacists in the provision of after-hours care for minor ailments.

 

“For a whole raft of reasons our emergency departments are under immense pressure,” PSA Tasmania President, Dr Ella van Tienen said. “Contributing to the burden are the number of presentations by patients with less-serious ailments, such as minor pain management or cold and flu.

 

“Recent research shows pharmacists have the skills and expertise to support patients who would currently seek care from a GP or hospital. Pharmacists can provide self-care advice, which in most cases is what is needed, or triage patients and refer them to the appropriate health service.

 

“Pharmacists are located throughout our local communities and a network are already open after-hours, making them well placed to do more. We estimate this initiative could save Tasmania’s health budget over $4 million a year.”

 

PSA is seeking funding of $2 million for a two-year pilot program under which pharmacists spread geographically access the state are incentivised to offer expanded after-hours service.

 

The budget submission also calls for $700,000 to enable a dedicated medicine safety pharmacist to work in each of the state’s five adult mental health services.

 

“Tasmania’s mental health outpatient facilities provide care to some of the most vulnerable members of our community. Medicines are a major treatment modality for many people with a mental illness and due to the nature of these medicines and complexity of medication regimes, there is increased risk of medication error and harm,” Dr van Tienen explained.

 

“Tasmania actually has the highest proportion of people dispensed with mental health-related prescriptions. To ensure these medicines are used safely we would like pharmacists more actively involved in the care team.”

 

Enabling pharmacists to provide a broader range of vaccinations would help further protect Tasmanians against preventable infectious diseases, PSA has argued.

 

“While this year has seen an expansion in scope of vaccines administered by pharmacists, we still lag behind other states in terms of allowing pharmacists to provide eligible Tasmanians with access to vaccines funded on the National Immunisation Program (NIP), such as influenza vaccinations” Dr van Tienen said. “With pharmacists located in rural and remote areas where other health professionals may be limited, these communities would benefit from access to NIP vaccinations through their local pharmacy.”

 

Supporting pharmacists to provide HPV and Hepatitis A vaccinations will also help remove barriers limiting Tasmanians from getting vaccinated and increase herd immunity.

 

“With around 200 pharmacist immunisers already fully trained, this recommendation could be quickly, cost effectively and safely implemented,” Dr van Tienen said. “In fact, we believe there is no direct budget investment required.

 

The second nil cost measure proposed by PSA is to expand the current pilot of the Hospital Liaison Pharmacist program to link back into the patient’s community pharmacists and ensure safe transfer of care at discharge.

 

“In terms of their health care journey, the point of hospital discharge presents one of the highest risks of medication error,” Dr van Tienen said. “Over 90 per cent of patients have at least one medication related problem post-discharge from hospital. As their community pharmacist is most likely to be the first health care provider a patient sees after hospital discharge the pharmacist can help patients understand, manage and adhere to their medication regime and prevent avoidable readmissions, but only if they are fully informed.”

 

PSA’s 2020-21 Tasmanian Budget Submission is available here.
Dr Ella van Tienen is available for interview and photographs

 

Media contact: Ella van Tienen 0419 335 893, media@psa.org.au

Health sector unites to turn the tide on medicine safety

Monday 9 December 2019

 

 

Better use of existing funding, leveraging digital health, empowering consumers and the workforce are among the keys to thinking and acting differently on medicine safety.

 

These were the themes resonating at a forum of stakeholders representing the breadth of health care, including government and consumers, held in Canberra today.

 

Convened by the Consumers Health Forum of Australia (CHF), Pharmaceutical Society of Australia (PSA), the Society of Hospital Pharmacists of Australia (SHPA), NPS MedicineWise and academic partners Monash University and University of Sydney, participants were challenged to ‘think differently’ on the safe use of medicines in Australia to turn the tide on this major health challenge.

 

“Medicine safety is a priority for us all and we each have a role to play,” PSA National President Associate Professor Chris Freeman said. “It was inspiring to see the sector work together today to proactively identify those measures we can cooperatively pursue to make a real difference and protect patients.”

“Improving medicine safety is not just about spending more money but also about being more strategic with the money that is spent.”
Medicine safety and quality use of medicines was recently declared the 10th National Health Priority Area by Commonwealth and state and territory health ministers.

 

CHF CEO, Leanne Wells, said: “Discussions often returned to how vital it is to have patients actively engaged in their health care decisions and informed about the medicines they are prescribed.

 

“Modern medication offers great benefits but the rate of hospital admissions caused by avoidable medication errors shows the importance of ensuring consumers are informed about their medicines, which is an integral part of broader quality use of medicines.

 

SHPA Chief Executive Kristin Michaels said: “The Medicine Safety Forum represents collaborative medicine leadership, which is crucial to ensuring Australians gain the greatest possible benefit from medicine use.

 

“The successful combination of effective medicine, provided in an accessible manner, with appropriate counselling and care from an expert workforce, will deliver the positive patient outcomes we all seek.”

 

NPS MedicineWise CEO Steve Morris said: “We need to cherish the ethos of quality use of medicines. While Australia’s National Strategy for the Quality Use of Medicines requires an update, the principles of 20 years ago, including the primacy of consumers, is just as relevant today.”

 

The cost of medicine-related harm is significant, estimated at more than $1.4 billion each year.

 

“Today there was deep discussion of the actions we can take to reduce harm from medicines. We will now take the feedback and ideas we received from participants and develop a suite of recommendations and work with relevant stakeholders to implement as a matter of urgency,” Associate Professor Freeman said.

 

“We’d like to thank the more than hundred experts who joined us today and thought outside the box to address one of Australia’s greatest healthcare challenges.
“The depth and number of participants at today’s Forum shows how important this issue is and how committed the health care sector is to improving medicine safety.”

 

A report on the outcomes of the Medicine Safety Forum, including recommendations will now be developed.

 

Media contact: PSA Media – 0487 922 176
Consumers Health Forum – Mark Metherell 0429 111 986
SHPA – Nick Sharp-Paul 0411 098 838

 

Download the media release here